BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: An Y, Xu S, Liu Y, Xu X, Philips CA, Chen J, Méndez-Sánchez N, Guo X, Qi X. Role of Galectins in the Liver Diseases: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021;8:744518. [PMID: 34778306 DOI: 10.3389/fmed.2021.744518] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Prikhodko VA, Bezborodkina NN, Okovityi SV. Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates. Biomedicines 2022;10:274. [DOI: 10.3390/biomedicines10020274] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
2 Fernández-Martín JC, Espinosa-Oliva AM, García-Domínguez I, Rosado-Sánchez I, Pacheco YM, Moyano R, Monterde JG, Venero JL, de Pablos RM. Gal3 Plays a Deleterious Role in a Mouse Model of Endotoxemia. Int J Mol Sci 2022;23:1170. [PMID: 35163089 DOI: 10.3390/ijms23031170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]